A double-blind randomised placebo-controlled trial of topical intranasal corticosteroids in 4- to 11-year-old children with persistent bilateral otitis media with effusion in primary care.
To determine the clinical effectiveness and cost-effectiveness of topical mometasone in children with bilateral otitis media with effusion (OME). A double-blind randomised placebo-controlled trial with an intention to treat analysis; the 10.6% of patients lost to follow-up at 1 month were censored i...
Váldodahkkit: | Williamson, I, Benge, S, Barton, S, Petrou, S, Letley, L, Fasey, N, Abangma, G, Dakin, H, Little, P |
---|---|
Materiálatiipa: | Journal article |
Giella: | English |
Almmustuhtton: |
2009
|
Geahča maid
-
A double-blind randomised placebo-controlled trial of topical intranasal corticosteroids in 4- to 11-year-old children with persistent bilateral otitis media with effusion in primary care
Dahkki: Williamson, I, et al.
Almmustuhtton: (2009) -
A double-blind randomised placebo-controlled trial of topical intranasal corticosteroids in 4- to 11-year-old children with persistent bilateral otitis media with effusion in primary care.
Dahkki: Williamson, I, et al.
Almmustuhtton: (2009) -
Cost-utility analysis of topical intranasal steroids for otitis media with effusion based on evidence from the GNOME trial.
Dahkki: Petrou, S, et al.
Almmustuhtton: (2010) -
Intranasal versus systemic corticosteroids in treatment of otitis media with effusion in the presence or absence of adenoid hypertrophy in children
Dahkki: Sayed M. S. Kadah, et al.
Almmustuhtton: (2019-08-01) -
Mapping analyses to estimate health utilities based on responses to the OM8-30 Otitis Media Questionnaire.
Dahkki: Dakin, H, et al.
Almmustuhtton: (2010)